Cereno Scientific participates in the Nordic-American Healthcare Conference 2023 (NAHC) in New York City
Cereno Scientific (Nasdaq First North: CRNO B), a company developing innovative treatments for common and rare cardiovascular disease, today announced that the company will participate at the Nordic-American Healthcare Conference 2023 (NAHC) on December 6-7, 2023, in New York City, US. The event is presented by DNB//Back Bay, Nasdaq, Innovation Norway, and Business Sweden.Sten R. Sörensen, CEO, will attend the 8th Annual Conference NAHC 2023 in New York City. The event takes place over two days in New York City, and is an invitation-only event. NAHC brings together leading Nordic